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Insulin-like growth factor 1 
modulates bioengineered tooth 
morphogenesis
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Masamitsu Oshima3, Takashi Tsuji2 & Teruko Takano-Yamamoto1,4
Regenerative therapy to replace missing teeth is a critical area of research. Functional bioengineered 
teeth have been produced by the organ germ method using mouse tooth germ cells. However, 
these bioengineered teeth are significantly smaller in size and exhibit an abnormal crown shape 
when compared with natural teeth. The proper sizes and shapes of teeth contribute to their normal 
function. Therefore, a method is needed to control the morphology of bioengineered teeth. Here, 
we investigated whether insulin-like growth factor 1 (IGF1) can regulate the sizes and shapes of 
bioengineered teeth, and assessed underlying mechanisms of such regulation. IGF1 treatment 
significantly increased the size of bioengineered tooth germs, while preserving normal tooth histology. 
IGF1-treated bioengineered teeth, which were developed from bioengineered tooth germs in subrenal 
capsules and jawbones, showed increased sizes and cusp numbers. IGF1 increased the number of 
fibroblast growth factor (Fgf4)-expressing enamel knots in bioengineered tooth germs and enhanced 
the proliferation and differentiation of dental epithelial and mesenchymal cells. This study is the first 
to reveal that IGF1 increases the sizes and cusp numbers of bioengineered teeth via the induction 
of enamel knot formation, as well as the proliferation and differentiation of dental epithelial and 
mesenchymal cells.
In the field of tooth regeneration, the ultimate goal is the regeneration of fully functional teeth in living bodies1. 
Tsuji’s group developed the organ germ method, which is a three-dimensional cell manipulation technique for the 
generation of bioengineered tooth germs2. Upon transplantation into the jawbones of mice, bioengineered tooth 
germs developed into bioengineered teeth and erupted into the oral cavity; these bioengineered teeth exhibited 
similar hardness to that of natural teeth, and were responsive to noxious stimuli3. These reports suggest that 
functional bioengineered teeth can be regenerated via transplantation of in vitro-generated bioengineered tooth 
germs into an edentulous area of the jaw.
The proper sizes and shapes of organs contribute to their normal function. There are site-specific types of 
teeth in the dentition, such as incisors, canines and molars. These have different sizes and shapes, and play unique 
roles in stomatognathic function and aesthetics. Tooth size reportedly affects the rate of food breakdown4; fur-
thermore, tooth shape correlates with masticatory efficiency5. From a clinical perspective, each patient exhibits 
individual sizes and shapes of teeth that are genetically and environmentally determined. Accordingly, the goal of 
dental regenerative therapy is to generate bioengineered teeth that erupt into the oral cavity, with sizes and shapes 
similar to those of natural teeth, in order to rehabilitate the aesthetics and stomatognathic function of individual 
patients. However, the bioengineered mouse teeth generated by Tsuji’s group were remarkably small in size and 
exhibited an abnormal crown shape, compared with that of natural teeth3. Therefore, a method is needed to con-
trol the morphology of bioengineered teeth.
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Tooth development progresses via interactions between dental epithelial and mesenchymal tissues1,6. Various 
molecules participate in spatio-temporal regulation of cellular processes, including proliferation and differentia-
tion, during tooth development1,6. Notably, molecules that affect tooth size and shape during tooth development 
could be useful for the morphological control of bioengineered teeth. Insulin-like growth factor 1 (IGF1) regu-
lates the normal development of various tissues, such as bone, muscle, and nerve, by regulating cell proliferation, 
differentiation, apoptosis, and migration7–9. Leprechaunism is a congenital syndrome associated with insulin 
resistance; it is characterized by retarded intrauterine and postnatal growth10. We previously reported a lepre-
chaunism patient who had undergone long-term treatment with recombinant IGF1 and had developed extremely 
large teeth11. Conversely, Sarnat et al.12 reported that patients with Laron-type dwarfism, which is characterized 
by the loss of growth hormone receptors, exhibit a deficiency in IGF1 secretion, such that they develop teeth 
with reduced mesiodistal width. Moreover, IGF1 and its receptor are expressed in both dental epithelial and 
mesenchymal tissues in tooth germs13,14; IGF1 signalling promotes cell proliferation, differentiation, and matrix 
secretion in mouse tooth germs15,16. Based on this previous evidence, we hypothesized that IGF1 regulates tooth 
morphogenesis, and can thus be used to control the size and shape of bioengineered teeth.
The aim of this study was to clarify whether IGF1 has the potential to control the size and shape of bioengi-
neered teeth. We transplanted bioengineered tooth germs, which were treated with IGF1 during organ culture, 
into the jawbones of living mice, in accordance with the method of our previous report3. The sizes and shapes of 
the developed bioengineered teeth were then examined. We further analysed the effects of IGF1 on enamel knot 
formation, as well as on the proliferation and differentiation of dental epithelial and mesenchymal cells in vitro, 
in order to elucidate the underlying biological mechanisms that cause morphological changes in IGF1-treated 
bioengineered teeth.
Results
IGF1 increases the size of tooth germs in culture. To investigate the effect of IGF1 on the morphogen-
esis of tooth germs in organ culture, we first treated tooth germs dissected from embryonic day (ED) 14.5 mouse 
mandibles with IGF1. As shown in Fig. 1a, the tooth germs exhibited increased size. Treatment with 4 µg/mL 
IGF1 significantly increased the height of tooth germs at days 7 and 14 (Fig. 1b). The width of IGF1-treated 
tooth germs became larger than that of control tooth germs at days 7 and 14 (Fig. 1c). Normal dental histological 
structure, comprising layers of ameloblasts, odontoblasts, enamel, and dentin, was observed in the control and 
IGF1-treated groups at day 14 of organ culture (Fig. 1d).
IGF1 increases the size of bioengineered tooth germs. First, to confirm the absence of cross- 
contamination of dental epithelial and mesenchymal cells (the sources of cells used for the generation of the 
bioengineered tooth germs) during the isolation procedure, we analysed the gene expression levels of the dental 
epithelial markers paired-like homeodomain transcription factor 2 (Pitx2), sonic hedgehog (Shh), and fibroblast 
growth factor 4 (Fgf4), as well as the expression level of the dental mesenchymal marker Fgf1017. Expression of 
Pitx2, Shh, Fgf4, and Fgf10 was observed in the tooth germs (Supplementary Figs S2 and S3). In dental epithelial 
tissues and cells, Pitx2, Shh, and Fgf4 were expressed, whereas Fgf10 was not (Supplementary Figs S2 and S3). 
In addition, Fgf10 was expressed in dental mesenchymal tissues and cells, whereas Pitx2, Shh, and Fgf4 were not 
(Supplementary Figs S2 and S3). These results indicated that there was no cross-contamination of dental epithelial 
and mesenchymal cells.
The contact length between reconstituted epithelial and mesenchymal cell layers affects the size of bioengi-
neered tooth germs generated by recombination of epithelium and mesenchyme and grown in an organ culture 
in vitro set-up18. Therefore, we generated tissue recombinants with a uniform contact length in the control and 
IGF1-treated groups. The bioengineered tooth germs formed a translucent zone between the epithelial and mes-
enchymal tissues at day 2, showed tooth crown shape at day 7, and grew further by day 14 (Fig. 2a, Supplementary 
Fig. S4). The heights and widths of the bioengineered tooth germs increased in a dose-dependent manner upon 
treatment with IGF1 (Fig. 2b,c). The heights of bioengineered tooth germs treated with 1, 2, 4, and 8 µg/mL IGF1 
were significantly greater than the heights of the control group germs at days 7 and 14 (Fig. 2b). The widths of 
the bioengineered tooth germs treated with 4 µg/mL were significantly larger than those of the control group at 
days 7 and 14 (Fig. 2c). The widths of the bioengineered tooth germs treated with 8 µg/mL IGF1 were significantly 
larger than those of the control group at day 7, but not at day 14 (Fig. 2c). The maximum effects of IGF1 on the 
height and width of the bioengineered tooth germs were observed at 4 µg/mL. These results indicated that IGF1 
increased the size of the bioengineered tooth germs.
Histological analysis of the bioengineered tooth germs in the control and IGF1-treated groups showed den-
tal papillae, odontoblasts, and ameloblast layers at day 7, as well as deposition of enamel and dentin matrix at 
day 14 (Fig. 2d); this indicated no histological differences between the groups. Immunohistochemical staining 
demonstrated IGF1 receptor (IGF1R) expression in ameloblasts, odontoblasts and dental papilla cells in the bio-
engineered tooth germs in both control and IGF1-treated groups at day 7 (Supplementary Fig. S5). The expres-
sion of IGF1R was also observed in ameloblasts and odontoblasts in the bioengineered tooth germs at day 14 of 
culture (Fig. 2e). Ameloblastin (AMBN), an enamel matrix protein secreted by ameloblasts19,20, was expressed in 
ameloblasts; dentin matrix acidic phosphoprotein 1 (DMP1), the extracellular matrix secreted by ameloblasts and 
odontoblasts21, was expressed in ameloblasts and at the junction area between dentin and predentin; and dentin 
sialoprotein (DSP), a component of the dentin extracellular matrix21, was expressed in predentin in both groups 
(Fig. 2e). Thus, obvious differences in the expression patterns of these proteins were not recognized between the 
control and IGF1-treated groups.
IGF1 increases the size and cusp number of bioengineered teeth developed in subrenal capsules. 
We examined the effect of IGF1 on the morphology of the bioengineered teeth. Transplantation of bioengineered 
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tooth germs into subrenal capsules resulted in the generation of bioengineered teeth with surrounding hard 
tissues in the control and IGF1-treated groups (Fig. 3a,b). The height of the bioengineered teeth in the group 
treated with 4 µg/mL IGF1 (1379.2 ± 177.7 µm, N = 8) was significantly greater than that in the control group 
(1151.2 ± 156.7 µm, N = 7) (Fig. 3c). The crown width of bioengineered teeth in the group treated with 4 µg/mL 
IGF1(582.3 ± 54.0 µm, N = 8) was also greater than that of teeth in the control group (503.8 ± 84.6 µm, N = 7) 
(Fig. 3d). Cusp number is a measurable aspect of tooth shape patterning22. Thus, we examined the cusp number 
of the bioengineered teeth to analyse the effect of IGF1 on bioengineered tooth morphology. The cusp number of 
bioengineered teeth in the group treated with 4 µg/mL IGF1 (4.5 ± 1.7, N = 8) was greater than that of teeth in the 
control group (2.4 ± 0.8, N = 7) (Fig. 3e).
IGF1-treated bioengineered teeth erupt from the jawbone with greater size and increased 
cusp number. We further examined whether the bioengineered teeth developed from the IGF1-treated 
Figure 1. IGF1 increases the size of natural tooth germs in organ culture. (a) Phase-contrast images of tooth 
germs derived from ED14.5 mouse mandible at days 0, 7, and 14 of organ culture in the control and IGF1-
treated groups. Scale bar, 200 µm. The height (b) and width (c) of tooth germs in the control and IGF1-treated 
groups at days 7 and 14 of organ culture. Error bars indicate the standard deviation (N = 9). *p < 0.05 (versus 
control group; Student’s t-test). (d) HE staining of the tooth germs at day 14 of organ culture in the control and 
IGF1-treated groups. Scale bar, 200 µm.
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bioengineered tooth germs could erupt from a jawbone with greater size and additional cusps. Eruption of the 
bioengineered teeth gradually progressed over 10 weeks after transplantation in both control and IGF1-treated 
groups without any pathological observations, such as ankylosis or bone defects (Fig. 4a). Quantitative analysis 
of micro-computed tomography images indicated greater height of bioengineered teeth in the group treated with 
4 µg/mL IGF1 (1500.8 ± 119.6 µm, N = 6) than in the control group (1340.6 ± 117.2 µm, N = 7) at 90 days after 
transplantation (Fig. 4b,c). The crown width of the bioengineered teeth in the group treated with 4 µg/mL IGF1 
(677.5 ± 83.8 µm, N = 6) was also significantly greater than that of teeth in the control group (497.9 ± 118.3 µm, 
N = 7) (Fig. 4b,d). Furthermore, the cusp number of bioengineered teeth in the group treated with 4 µg/mL IGF1 
(4.8 ± 0.8, N = 6) was greater than that of teeth in the control group (3.3 ± 1.4, N = 7) (Fig. 4e).
Periodontal ligament (PDL) is a fibrous tissue located between the tooth root and alveolar bone23. PDL sur-
rounding the bioengineered tooth root was observed in the control and IGF1-treated groups (Fig. 4f). IGF1 did 
not visibly affect the histology of the PDL (Fig. 4f). We investigated the expression of the nerve fibre marker, 
neurofilament (NF), and the vascular endothelial cell marker, von Willebrand factor (VWF), in the PDL. NF and 
VWF were expressed in the PDL in both control and IGF1-treated groups. There were no clear differences in 
the expression patterns of NF and VWF in the PDL surrounding control and IGF1-treated bioengineered teeth 
(Fig. 4g,h).
IGF1 does not affect the hardness of bioengineered teeth. To analyse the effect of IGF1 on the hard-
ness of the bioengineered teeth, we measured Knoop hardness. The Knoop hardness number (KHN) value of 
the enamel of natural teeth was 433.7 ± 131.1 (N = 6) (Fig. 5a). The KHN values of the enamel of bioengineered 
teeth developed by renal subcapsular transplantation showed no significant difference between the control group 
Figure 2. IGF1 increases the size of bioengineered tooth germs. (a) Phase-contrast images of tissue 
recombinants at day 0 and bioengineered tooth germs at days 7 and 14 of organ culture in the control and 
IGF1-treated groups. Scale bar, 200 µm. The height (b) and width (c) of bioengineered tooth germs at days 
7 and 14 in the control and IGF1-treated groups. Error bars indicate the standard deviation (N = 6 or 7). 
*p < 0.05, **p < 0.01 (versus 0 µg/mL group; one-way analysis of variance followed by the Tukey-Kramer test). 
(d) HE staining of bioengineered tooth germs at days 7 and 14 in the control and IGF1-treated groups. AM, 
ameloblasts; D, dentin; DP, dental papilla; E, enamel; OB, odontoblasts; PD, predentin. Scale bar, 20 µm. (e) 
Immunohistochemical staining of IGF1R, AMBN, DMP1, and DSP in bioengineered tooth germs at day 14 of 
culture in the control and IGF1-treated groups. Scale bar, 20 µm.
www.nature.com/scientificreports/
5SCIENTIFIC REPORTS |           (2019) 9:368  | DOI:10.1038/s41598-018-36863-6
(201.6 ± 19.9 KHN, N = 7) and the group treated with 4 µg/mL IGF1 (210.9 ± 17.9 KHN, N = 5); notably, both 
were significantly lower than the value of natural tooth enamel (Fig. 5a). The KHN values of the enamel of bioen-
gineered teeth developed by transplantation into jawbones showed no significant difference between the control 
group (393.1 ± 20.1 KHN, N = 5) and the group treated with 4 µg/mL IGF1 (404.6 ± 19.2 KHN, N = 5); these val-
ues were similar to the value of natural tooth enamel (Fig. 5a). The KHN values of the dentin of the bioengineered 
teeth developed in subrenal capsules were 81.7 ± 9.5 (N = 7) in the control group and 81.1 ± 8.5 (N = 5) in the 
group treated with 4 µg/mL IGF1 (Fig. 5b). The KHN values of the dentin of the bioengineered teeth developed in 
jawbones were 89.7 ± 4.6 (N = 5) in the control group and 79.9 ± 4.2 (N = 5) in the group treated with 4 µg/mL IGF1 
(Fig. 5b). These dentin KHN values were comparable to those of natural teeth (90.7 ± 7.1 KHN, N = 6) (Fig. 5b).
IGF1 increases the number of Fgf4-expressing enamel knots during the development of bioen-
gineered tooth germs. The formation of enamel knots, a cluster of non-dividing epithelial cells, is a critical 
biological process for the patterning of tooth cusps24,25. To analyse the effect of IGF1 on enamel knot formation, 
we measured the expression of the enamel knot marker, Fgf4, during the development of the bioengineered tooth 
germs24,25. Fgf4 expression was not detectable at day 1 (Fig. 6a). Its expression was observed in both groups at 
day 2; notably, the number of Fgf4-expressing sites increased during the development of the bioengineered tooth 
germs (Fig. 6a). The number of Fgf4-expressing sites at day 5 in the group treated with 4 µg/mL IGF1 (4.3 ± 0.5, 
N = 6) was significantly larger than that of the control group (3.2 ± 0.4, N = 6) (Fig. 6b,c).
Figure 3. IGF1 increases the size and cusp number of bioengineered teeth developed in subrenal capsules. 
Stereomicroscopy images (a) and micro-CT images (b) of bioengineered teeth at 30 days after renal subcapsular 
transplantation in the control and IGF1-treated groups. Scale bar, 600 µm. The height (c), width (d), and 
cusp number (e) of bioengineered teeth at 30 days after renal subcapsular transplantation in the control and 
IGF1-treated groups. Error bars indicate the standard deviation (N = 7 or 8). *p < 0.05 (versus control group; 
Student’s t-test).
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Figure 4. IGF1-treated bioengineered teeth erupt from the jawbone with greater size and increased cusp 
number. (a) Micro-CT images of the bioengineered tooth in the control and IGF1-treated groups at 2, 4, 6, 8, 
and 10 weeks after transplantation. The bioengineered teeth are indicated by arrowheads. Scale bar, 500 µm.  
(b) Micro-CT images of bioengineered teeth in the control and IGF1-treated groups at 90 days after 
transplantation into jawbones. The bioengineered teeth are indicated by arrowheads. Scale bar, 600 µm.  
The height (c), width (d), and cusp number (e) of bioengineered teeth at 90 days after transplantation into 
jawbones in the control and IGF1-treated groups. Error bars indicate the standard deviation (N = 6 or 7). 
*p < 0.05 (versus control group; Student’s t-test). Periodontal ligament surrounding the root of bioengineered 
teeth developed in jawbones was examined by HE staining (f) and immunofluorescence analysis of NF (g) and 
VWF (h). NF and VWF are indicated by arrowheads. Scale bar, 20 µm. PDL, periodontal ligament; T, tooth.
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IGF1 directly upregulates the proliferation of both mesenchymal and epithelial cells derived 
from tooth germs. To investigate the mechanisms of the IGF1-mediated enhancement in the size of bio-
engineered teeth, we analysed the effect of IGF1 on the proliferation of dental mesenchymal and epithelial 
cells isolated from ED14.5 mouse tooth germs. The total cell number and percentage of bromodeoxyuridine 
(BrdU)-positive mesenchymal cells were significantly higher in the IGF1-treated group than in the control group 
(Fig. 7a−d). A significant increase in the total cell number and percentage of BrdU-positive epithelial cells was 
also observed in the IGF1-treated group (Fig. 7e–h).
IGF1 stimulates the differentiation of mesenchymal and epithelial cells derived from tooth germs. 
Previous reports indicate that the interaction of IGF1 and bone morphogenetic protein 2 (BMP2) signalling 
contributes to the development of various tissues, including tooth, bone, and cartilage26–28. Both Igf1 and 
Igf1r were expressed in dental epithelial and mesenchymal tissues in the ED14.5 tooth germs, while Bmp2 was 
expressed solely in dental epithelial tissue (Supplementary Figs S6 and S7). We then examined the effect of IGF1 
on the odontoblast differentiation of dental mesenchymal cells, focusing on its potential interaction with BMP2. 
Phase-contrast micrographs revealed a polygonal cell shape in the control and IGF1-treated groups at day 10 
of culture (Fig. 8a). In contrast, mesenchymal cells in the BMP2-treated and BMP2 plus IGF1-treated groups 
were spindle-shaped (Fig. 8a). Dentin sialophosphoprotein (Dspp), Dmp1, and microtubule-associated protein 1b 
(Map1b) are known as odontoblast markers21,29. Expression of Dmp1, Map1b, and Dspp was clearly induced by 
the simultaneous administration of IGF1 and BMP2, whereas treatment with IGF1 or BMP2 alone did not induce 
expression of these markers (Fig. 8b–d). Next, we examined the effect of IGF1 and BMP2 on the expression of 
insulin-like growth factor-binding proteins (IGFBPs), which regulate IGF1 bioactivity30. The expression levels of 
Igfbp2, 3, and 4 were significantly reduced, while the expression of Igfbp6 was significantly enhanced by BMP2 
treatment, as well as by simultaneous administration of IGF1 and BMP2 (Fig. 8e–h).
We examined the effect of IGF1 on the differentiation of dental epithelial cells. The epithelial cells reached 
confluence and showed polygonal shape at day 4 of culture (Fig. 8i). IGF1 treatment did not visibly alter the shape 
of the epithelial cells (Fig. 8i). Ambn is considered a marker of ameloblast differentiation19,20. Analysis of Ambn 
Figure 5. IGF1 does not affect the hardness of bioengineered teeth. The Knoop hardness values of the enamel 
(a) and dentin (b) of bioengineered teeth in the control and IGF1-treated groups at 30 days after transplantation 
into subrenal capsules (SRC), and at 90 days after transplantation into jawbones (TP), were assessed and 
compared with those of the upper first molars in 9-weeek-old-C57BL/J mice (NT, natural tooth). Error bars 
indicate the standard deviation (N = 5−7). The different letters (a, b, and c) indicate significant differences 
between groups. p < 0.05 (one-way analysis of variance followed by the Tukey-Kramer test).
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expression demonstrated significantly greater expression of Ambn in the IGF1-treated group than in the control 
group (Fig. 8j–l).
Discussion
In the present study, we analysed the effect of IGF1 on the morphology of bioengineered teeth. We demonstrated 
that IGF1 treatment significantly increased the size of bioengineered tooth germs while maintaining normal 
dental histological architecture. IGF1 binds to IGF1R with high affinity and activates its signalling pathway31,32. 
IGF1R expression was observed in ameloblasts, odontoblasts, and dental papilla cells during the development of 
bioengineered tooth germs; these IGF1R expression patterns were similar to those of normal tooth germs33–35. 
Our findings suggest that IGF1 increases the size of bioengineered tooth germs by acting on both epithelial and 
mesenchymal cells. Moreover, the IGF1-treated bioengineered teeth, which were developed from bioengineered 
tooth germs in subrenal capsules and jawbones, showed an increase not only in size but also in cusp number. 
These findings indicated for the first time that IGF1 is a competent agent for increasing the size and cusp number 
of bioengineered teeth. Importantly, IGF1 treatment did not interfere with the formation of PDL surrounding 
tooth roots and the acquisition of significant hardness of enamel and dentin. PDL has essential roles in tooth 
function, such as perception, adaptation to mechanical load, and homeostasis of teeth and periodontal tissues36. 
Sufficient tooth hardness is required to exert masticatory potential37. Therefore, the IGF1-treated bioengineered 
teeth could exert normal physiological function as related to PDL and tooth hardness.
The biological effects of pharmaceutical agents are dependent on their concentration. We demonstrated that IGF1 
increased the size of bioengineered teeth in a dose-dependent manner, representing maximum effects at 4 μg/mL. 
Figure 6. IGF1 increases the number of Fgf4-expressing sites during the development of bioengineered 
tooth germs. (a) The expression of Fgf4 in bioengineered tooth germs was examined by whole-mount in situ 
hybridization at days 1, 2, 3, and 4 of organ culture in the control and IGF1-treated groups. Scale bar, 200 µm. 
(b) The expression of Fgf4 in bioengineered tooth germs at day 5 of organ culture in the control and IGF1-
treated groups was examined by whole-mount in situ hybridization. Scale bar, 200 µm. (c) The number of  
Fgf4-expressing sites was counted. Error bars indicate the standard deviation (N = 6). **p < 0.01 (versus control 
group; Student’s t-test).
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The physiological concentration of IGF1 in the serum of 4–8-week-old mice is approximately 0.4–1 μg/mL8,38. 
Therefore, the concentration of IGF1 used in the present study is higher than the physiological level. However, the 
histological structure and the expression patterns of IGF1R and enamel and dentin matrix proteins in the bioen-
gineered tooth germs treated with 4 μg/mL IGF1 showed no abnormal changes when compared with the control 
group. In addition, pathological findings such as cell necrosis and tissue degeneration were not observed. Therefore, 
the concentration of IGF1 used in the present study had no adverse effect on the bioengineered tooth germs.
We transplanted the bioengineered tooth germs, which had been cultured with IGF1 for 7 days, into mouse 
subrenal capsules and jawbones. Although exogenous IGF1 was not administered after the transplantation, 
the generated bioengineered teeth showed increased size and cusp number. Kim et al.39 cultured tooth germs 
extracted from ED13.5 mice with the administration of a caspase inhibitor for 2 days, and subsequently trans-
planted them into mouse subrenal capsules. As a result, teeth with shorter crown heights and wider mesiodistal 
diameters were generated despite no further administration of the inhibitor to the mice. These findings indicate 
that the ex vivo effects of agents on the morphology of bioengineered tooth germs are maintained during their 
development into bioengineered teeth in the living body. This concept is significant for the future clinical appli-
cation of IGF1 to regulate the morphology of bioengineered teeth.
During tooth germ development, epithelial cells form the enamel knot at the tip of the cap-shaped tooth 
germ (cap stage)40. During the progression of tooth development, the number of enamel knots increases and the 
location of future cusps is determined25. BMP2 expression in dental epithelium induces the formation of enamel 
knots41. BMP4 expression in dental mesenchyme also contributes to enamel knot formation via upregulation 
of p21 and Msh homeobox 1 (Msx1)41. However, the molecular mechanism of enamel knot formation is not 
fully understood. In the present study, IGF1 increased the number of Fgf4-expressing sites in bioengineered 
tooth germs, indicating that IGF1 directly and/or indirectly contributes to the production of enamel knots. FGF4 
expression in enamel knots upregulates the proliferation of peripheral dental epithelial and mesenchymal cells 
during tooth morphogenesis24. Kratochwil et al.42 reported that FGF4 expression in enamel knots induces the 
expression of SHH in dental epithelium, which is an essential factor for tooth morphogenesis, via upregulation of 
FGF3 in dental mesenchyme. Our data suggest that the IGF1-induced FGF4 in enamel knots could activate pro-
liferation and downstream signalling, subsequently increasing the size and cusp number of bioengineered teeth. 
The IGF1-dependent increase in the number of enamel knots could subsequently increase the cusp number in 
Figure 7. IGF1 directly upregulates the proliferation of mesenchymal and epithelial cells derived from tooth 
germs. (a) Phase-contrast images of mesenchymal cells isolated from mandibular molar tooth germs of ED14.5 
mice at day 3 of culture. Scale bar, 200 µm. (b) BrdU-positive dental mesenchymal cells (green) were analysed 
by immunofluorescence. Nuclei were stained with DAPI (blue). Scale bar, 100 µm. Total numbers of dental 
mesenchymal cells (c) and percentages of BrdU-positive cells (d) were analysed on the immunofluorescent 
images. Error bars indicate the standard deviation (N = 3). *p < 0.05 (versus control group; Student’s t-
test). (e) Phase-contrast images of epithelial cells isolated from mandibular molar tooth germs of ED14.5 
mice at day 2 of culture. Scale bar, 200 µm. (f) BrdU-positive dental epithelial cells (green) were analysed by 
immunofluorescence. Nuclei were stained with DAPI (blue). Scale bar, 100 µm. The total numbers of dental 
epithelial cells (g) and percentages of BrdU-positive cells (h) were analysed on the immunofluorescent images. 
Error bars indicate the standard deviation (N = 3). *p < 0.05 (versus control group; Student’s t-test).
www.nature.com/scientificreports/
1 0SCIENTIFIC REPORTS |           (2019) 9:368  | DOI:10.1038/s41598-018-36863-6
bioengineered teeth. On the other hand, generation of more space between enamel knots during growth of tooth 
germs would allow the formation of new enamel knots, regulated by activators and inhibitors of enamel knot 
formation43. Thus, it is possible that the IGF-induced increase in the size of bioengineered tooth germs indirectly 
increases the total number of enamel knots via activator-inhibitor loops. We need further study to elucidate regu-
latory mechanisms of the IGF-induced increase in the size and cusp number of bioengineered teeth.
Regarding the role of IGF1 in the proliferation of tooth germ cells, Young et al.15 showed an inducible effect of 
IGF1 on mitotic activity in the dental epithelial cells of ED16 mouse molar tooth germs. Caton et al.44 reported that 
IGF1 induces proliferation of dental mesenchymal cells isolated from ED18 mouse molar tooth germs. However, 
the effect of IGF1 on the proliferation of mesenchymal and epithelial cells in stage of tooth germ development 
earlier than ED16 has not been clarified. In the present study, we revealed for the first time, that IGF1 directly 
enhanced the proliferation of both dental mesenchymal and epithelial cells isolated from the tooth germs of 
ED14.5 mice in vitro. In the molar tooth germ of ED14 mice, epithelial tissue invaginates around the mesenchymal 
Figure 8. IGF1 stimulates the differentiation of mesenchymal and epithelial cells derived from tooth germs. (a) 
Phase-contrast images of mesenchymal cells isolated from the mandibular molar tooth germ of ED14.5 mice 
at day 10 of culture in the control, IGF1-treated, BMP2-treated, and IGF1 plus BMP2-treated groups. Scale 
bar, 100 µm. mRNA expression levels of Dmp1 (b), Map1b (c), Dspp (d), Igfbp2 (e), Igfbp3 (f), Igfbp4 (g) and 
Igfbp6 (h) were quantitatively analysed by real-time PCR. Error bars indicate the standard deviation (N = 3). 
*p < 0.05, **p < 0.01 (one-way analysis of variance followed by the Tukey-Kramer test). (i) Phase-contrast 
images of epithelial cells isolated from the mandibular molar tooth germs of ED14.5 mice at day 4 of culture in 
the control and IGF1-treated groups. Scale bar, 200 µm. (j) Expression of AMBN (green) in the dental epithelial 
cells was analysed by immunofluorescence. Nuclei were stained with DAPI (blue). Scale bar, 100 µm. (k) The 
immunofluorescent signal of AMBN was quantitatively analysed. Data are expressed as integrated density/
cell. Error bars indicate the standard deviation (N = 3). **p < 0.01 (versus control group; Student’s t-test). (l) 
The Ambn mRNA expression was quantitatively analysed by real-time PCR. Error bars indicate the standard 
deviation (N = 3). **p < 0.01 (versus control group; Student’s t-test).
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tissue, reaching the cap stage45. Subsequently, the size of tooth germs increases as the dental epithelial tissue fur-
ther invaginates and elongates into mesenchymal tissue by active cell proliferation; the tooth germ then forms a 
bell-shaped crown at ED16 (bell stage)45. Thus, our data suggest that IGF1 contributes to increased tooth germ size 
by stimulating the proliferation of dental mesenchymal and epithelial cells between the cap and bell stages. The 
direct effect of IGF1 on proliferation may provide a mechanism to increase the size of bioengineered teeth.
Dental mesenchymal cells begin to differentiate into odontoblasts by signallings from the enamel knot in the 
bell stage46; dental epithelial cells begin to differentiate into ameloblasts following odontoblast differentiation46. 
During the late bell stage, differentiated odontoblasts and ameloblasts form dentin and enamel, which are dental 
hard tissues, and teeth develop with increasing size38. Thus, we analysed the effect of IGF1 on odontoblast and 
ameloblast differentiation of dental mesenchymal and epithelial cells isolated from ED14.5 mouse molar tooth 
germs, in order to further elucidate the mechanism for the increased size of bioengineered teeth.
In the present study, we showed that expression of odontoblast markers Dmp1, Dspp, and Map1b was not 
induced by IGF1 in dental mesenchymal cells. Expression of these markers was also not induced by BMP2. 
In contrast, simultaneous administration of IGF1 and BMP2 resulted in significant induction of these marker 
genes. Bègue-Kirn et al.47 also showed that the combination of IGF1 and BMP2 promotes odontoblast differen-
tiation by histological analysis of organ-cultured dental papilla tissue isolated from ED17 mouse tooth germs; 
IGF1 or BMP2 alone does not promote this differentiation. These findings suggest that BMP2 is essential for 
IGF1-induced differentiation of dental mesenchymal cells into odontoblasts.
We then analysed expression of IGFBPs, which regulate the biological action of IGF1, to elucidate the mech-
anism by which simultaneous administration of IGF1 and BMP2 induces differentiation of dental mesenchy-
mal cells into odontoblasts. We found decreased expression of Igfbp2, 3, and 4; notably, expression of Igfbp6 
was increased by BMP2, with or without IGF1 administration. Takahashi et al.28 showed that BMP2 decreased 
the expression of IGFBP3 in neonatal bovine chondrocytes. These findings suggest that BMP2 is a modulator 
of IGFBP expression. IGFBP2, 3, and 4 inhibit the bioactivity of IGF1 by interfering with IGF1 binding to its 
receptor30. Thus, activation of IGF1 signalling due to reduced expression of IGFBP2, 3, and 4 by BMP2 consti-
tutes the mechanism by which simultaneous administration of IGF1 and BMP2 induces differentiation of dental 
mesenchymal cells into odontoblasts. Additionally, IGFBP6 has high binding affinity for IGF2 and suppresses 
the activity of IGF230. However, IGFBP6 has low binding affinity for IGF1 and its effect on IGF1 activity remains 
uncleared30. Moreover, although IGFBP6 suppresses the differentiation of oligodendrocyte precursor cells, and 
osteoblasts48,49, its role in the differentiation of dental cells has not been reported. Further studies are necessary to 
clarify the role of BMP2-induced IGFBP6 in odontoblast differentiation.
In the present study, we showed that the expression of the enamel matrix gene Ambn was enhanced upon IGF1 
treatment of cultured dental epithelial cells. Takahashi et al.50 showed that IGF1 increased the expression of Ambn 
in organ-cultured ED15 mouse molar tooth germs. However, it is not clear whether IGF1 directly increases the 
expression of Ambn in dental epithelial cells, because tooth development progresses through various signalling 
crosstalk mechanisms between epithelial and mesenchymal tissues. The present study showed that the expression 
of Ambn was directly enhanced by IGF1 in dental epithelial cells. Ambn is expressed earlier than other enamel 
matrix genes, such as Enam and Amel, during tooth germ development51. Because Ambn-null mice exhibited 
severe enamel hypoplasia and reduced expression of Amel, Ambn may play an essential role in normal ameloblast 
differentiation20. Therefore, IGF1-induced Ambn would induce the ameloblasts differentiation during the devel-
opment of bioengineered tooth germs.
IGF1 plays a role in increasing the size of various organs, such as the kidneys, liver, spleen, and bones, during 
postnatal growth of rats and mice52,53. Therefore, our findings contribute to a novel strategy for the morphNolog-
ical control of bioengineered organs (not strictly limited to teeth) by the activation of IGF1 signalling.
Methods
Ethics statement. C57BL/6 mice were purchased from CLEA Japan (Tokyo, Japan). Animal experiments 
were performed in accordance with the Regulations for Animal Experiments and Related Activities at Tohoku 
University. All animal protocols were approved by the Institutional Animal Care and Use Committee of the 
Tohoku University Environmental and Safety Committee.
Generation of bioengineered tooth germs from single cells. Bioengineered tooth germs were gen-
erated as described previously2. Molar tooth germs were dissected from the mandibles of ED14.5 C57BL/6 mice. 
To generate tissue recombinants, 5.0 × 104 epithelial and mesenchymal cells each in 0.05 µL were injected into 
30-µL collagen gel drops of Cellmatrix type I-A (Nitta Gelatin, Osaka, Japan) using a Hamilton syringe (Osaka 
Chemical, Osaka, Japan). Recombinant mouse IGF1 (R&D Systems, McKinley, Minneapolis, MN, USA) (0.5, 1, 
2, 4, and 8 µg/mL) was added to the gel drops in the IGF1-treated group.
Organ culture. Collagen gel drops with tissue recombinants were incubated for 10 min at 37 °C, transferred 
to a cell culture insert (0.4-µm pore diameter; Becton Dickinson, Franklin Lakes, NJ, USA) in 24-well cell cul-
ture plates (BD), and cultured with 250 µL/well Dulbecco’s modified eagle medium (DMEM; Sigma, St. Louis, 
MO, USA) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA), 100 units/mL of pen-
icillin, and 100 µg/mL of streptomycin (Invitrogen, Carlsbad, CA, USA). On the next day, the culture medium 
was changed to DMEM containing 10% FBS, 100 units/mL of penicillin, 100 µg/mL of streptomycin, 2 mM 
L-glutamine (Sigma), and 100 µg/mL ascorbic acid (Sigma). The medium was then changed every other day. 
The tooth germs were dissected from mandibles of ED14.5 mice and then cultured in accordance with the same 
protocol as for tissue recombinants.
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Transplantation of bioengineered tooth germs into subrenal capsules. Bioengineered tooth 
germs isolated from collagen gel after 7-day-organ culture were placed into plastic ring-shaped devices with 
2.5-mm internal diameter and 1.3-mm thickness. These were transplanted into subrenal capsules of 7-week-old 
C57BL/6 mice under general anaesthesia, as described previously54.
Transplantation of tooth germs into jawbones. Transplantation of bioengineered tooth germs into 
jawbones was performed as described previously3. Upper first molars of 5-week-old C57BL/6 mice were extracted 
under general anaesthesia and maintained for 3 weeks to allow natural repair of the tooth cavity and oral epithe-
lium. Then, the oral mucosa at the extraction sites was incised and bony holes (0.8 mm in diameter and 1.5 mm 
in depth, one hole per site) were made by a dental micro motor (PAL; Morita, Osaka, Japan). Bioengineered 
tooth germs were isolated from collagen gel after 7-day-organ culture, marked at the top of the dental epithelium 
with methylene blue to confirm the direction, and transplanted into the bony holes. The incised oral mucosa was 
sutured with 8–0 nylon (BEAR Medic, Chiba, Japan).
Micro-computed tomography (Micro-CT). Micro-CT images of bioengineered teeth developed in subre-
nal capsules and jawbones were obtained by R_mCT2 (Rigaku, Tokyo, Japan) or Latheta LCT-200 (Hitachi, Aloka 
Medical, Tokyo, Japan). The micro-CT images were reconstructed and analysed using i-VIEW-3DX (Morita) or 
TRI/3D-BON (Ratoc System Engineering, Tokyo, Japan).
Measurement of Knoop hardness. Bioengineered teeth were extracted 30 and 90 days after transplanta-
tion into subrenal capsules and jawbones, respectively. Upper first molars of 9-week-old C57BL/6 mice were also 
extracted. These samples were immersed in 4% paraformaldehyde (PFA); then, flat surfaces of enamel and dentin 
were made. Knoop hardness was measured using a Miniload Hardness Tester (Mitutoyo, Tokyo, Japan) equipped 
with a Knoop diamond tip (Mitutoyo). Five indentations were made on each sample with a 10-g load for 10 sec.
Histological analysis. Bioengineered and natural tooth germs, as well as jawbones with bioengineered 
teeth, were immersed in 4% PFA and decalcified in 4.5% EDTA at 4 °C, as described previously2. After decalcifi-
cation, the samples were embedded in paraffin and cut into sections. The sections were deparaffinized and stained 
with haematoxylin and eosin (HE).
Immunohistochemistry. To examine the expression of AMBN, deparaffinized sections were immersed in 
0.1 M citrate buffer, boiled by microwave for 2 min, and incubated at room temperature for 30 min. The sections 
were washed with phosphate-buffered saline (PBS), treated with 3% H2O2 in methanol for 15 min at room tem-
perature, and incubated with an anti-AMBN antibody (1:500, diluted in PBS; Santa Cruz Biotechnology, Dallas, 
TX, USA) at 4 °C overnight. The sections were incubated with Histofine Simplestain Max PO (Nichirei, Tokyo, 
Japan) for 30 min at room temperature. Signals were detected by reaction with 3,3′-diaminobenzidine tetrahydro-
chloride (DAB; Nichirei, Tokyo, Japan).
Deparaffinized sections were immersed in 0.1 M citrate buffer for 2 h at 37 °C to examine the expression of 
IGF1R and in 1.0 mg/mL hyaluronidase (Sigma) for 1 h at 37 °C to examine the expression of DMP1 and DSP. 
The sections were treated with 3% H2O2 for 5 min at room temperature and then incubated with anti-IGF1R 
(1:50; Merck Millipore, Darmstadt, Germany), anti-DMP1 (1:50; Merck Millipore), or anti-DSP (1:250; Merck 
Millipore) antibodies for 30 min at room temperature using the VECTOR M.O.M Immunodetection Kit (Vector 
Laboratories, Burlingame, CA, USA), in accordance with the manufacturer’s protocol. The sections were incubated 
with VECTASTAIN Elite ABC Reagent (Vector Laboratories) and signals were detected by reaction with DAB.
To analyse the expression of NF and VWF, deparaffinized sections were treated with 0.15% Triton-X100 in PBS 
for 30 min at room temperature. After sections were blocked with 1% goat serum (Vector Laboratories) in PBS for 
1 h at room temperature, they were incubated with anti-NF (1:200; Chemicon, Temecula, CA, USA) or anti-VWF 
(1:1000; Dako, Glostrup, Denmark) antibodies for 2 h at room temperature. After sections were washed with 0.1% 
Tween 20 in PBS, they were treated with goat anti-rabbit IgG Alexa 488 (1:1000; Invitrogen) for 1 h at room tem-
perature. Nuclei were stained with 4’,6-diamidino-2-phenylindole (DAPI; 1:1000; KPL, Gaithersburg, MD, USA). 
Samples were visualized using a confocal laser scanning microscope system (C2si; Nikon Instech, Tokyo, Japan).
Immunocytochemistry. Epithelial cells isolated from the mandibular first molar tooth germs of ED14.5 
C57BL/6 mice were seeded at a density of 1.5 × 105 cells/cm2 on glass-bottomed dishes coated with 20 µg/mL 
fibronectin (Sigma) and 100 µg/mL type IV collagen (Nitta Gelatin) and cultured in CnT-Prime medium 
(CELLnTEC, Bern, Switzerland). On the next day, 500 ng/mL IGF1 was added into the medium. After 4-day cul-
ture, cells were fixed using 4% PFA for 15 min and treated with 0.1% Triton-X100 in PBS for 15 min at room tem-
perature. After cells were blocked with 3% bovine serum albumin (Sigma) in PBS for 1 h at room temperature, they 
were incubated with an anti-AMBN antibody (1:100; Santa Cruz Biotechnology Inc.) overnight at 4 °C. Cells were 
treated with goat anti-rabbit IgG Alexa 488 (1:1000; Invitrogen) for 1 h at room temperature. Nuclei were stained 
with DAPI (1:1000; KPL). Signals were visualized using C2si (Nikon Instech). Integrated density measurements of 
five microscopic fields in each sample were performed using ImageJ software (https://imagej.nih.gov/ij/).
Probe preparation and whole-mount in situ hybridization. Digoxigenin-labelled RNA probes were 
prepared with the MAXIscript Kit (Thermo Fisher Scientific, Waltham, MA, USA), in accordance with the man-
ufacturer’s instructions. The DNA fragment of Fgf4 (NM_010202, located between 117 and 731) was amplified 
by polymerase chain reaction (PCR), using primers shown in Supplementary Table S1. The fragment was sub-
cloned into the pGEM-T vector (Promega, Madison, WI, USA) and used to generate sense and antisense probes. 
Bioengineered tooth germs after 5-day organ culture were fixed in 4% PFA overnight at 4 °C, treated with 6% H2O2 
and 0.1% Tween 20 in PBS at room temperature, and incubated with 10 µg/mL proteinase K (Roche, Mannheim, 
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Germany) for 3 min at 30 °C. After post-fixation and prehybridization, samples were hybridized overnight at 70 °C 
with digoxigenin-labelled RNA probes. Samples were blocked with 10% normal sheep serum (Sigma) and then 
incubated with anti-digoxigenin antibody conjugated with alkaline phosphatase (Roche), overnight at 4 °C. Nitro 
blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate (Roche) were used for signal detection.
BrdU assay. Mesenchymal and epithelial cells were isolated from the mandibular molar tooth germs of E14.5 
C57BL/6 mice. Mesenchymal cells were seeded on glass-bottomed dishes at a density of 2.0 × 104 cells/cm2 and 
cultured in DMEM supplemented with 10% FBS, 100 units/mL of penicillin, and 100 µg/mL of streptomycin. On 
the next day, IGF1 (500 ng/mL) was added into the medium. Epithelial cells were seeded at a density of 7.5 × 104 
cells/cm2 on glass-bottomed dishes coated with 20 µg/mL fibronectin (Sigma) and 100 µg/mL type IV collagen 
(Nitta Gelatin); the cells were cultured in CnT-Prime medium (CELLnTEC). After 3-day culture of mesenchymal 
cells and 2-day culture of epithelial cells, cells were incubated with DMEM supplemented with 1% BrdU Labeling 
Reagent (Invitrogen) for 4 h at 37 °C, then fixed with 70% ethanol for 15 min at 4 °C. The cells were treated with 
0.1% Triton-X100 in PBS for 20 min at room temperature, then with Denaturing Solution (BrdU Staining Kit, 
Invitrogen) for 30 min at room temperature. Cells were treated with 0.1% Triton-X100 and 5% normal goat serum 
in PBS for 1 h at room temperature and incubated with Alexa Fluor 488-conjugate BrdU antibody (1:100; Thermo 
Fisher Scientific) overnight at room temperature. Nuclei were stained with DAPI (1:1000; KPL). Samples were 
visualized using C2si (Nikon Instech). Counts of total and BrdU-positive cell numbers were performed using five 
microscopic fields in each sample.
PCR. Total RNA was isolated from whole mandibular first molar tooth germ, dental mesenchymal and epithe-
lial tissues, and mesenchymal and epithelial cells isolated from tooth germs in E14.5 mice, using the RNeasy Kit 
(Qiagen, Valencia, CA, USA). cDNA was synthesized from 0.4 µg total RNA using the PrimeScript RT Reagent Kit 
(Takara Bio, Shiga, Japan). Conventional reverse transcription-PCR (RT-PCR) was performed by Veriti™ 96-Well 
Thermal Cycler (Applied Biosystems, Foster City, CA, USA). The reaction volume was 50 µL, which contained 
2 µL of cDNA, 0.4 µM of sense and antisense primer, and 25 µL of EmeraldAmp® PCR Master Mix (Takara Bio). 
The reactions consisted of gene-specific numbers of cycles (Pitx2: 28 cycles, Shh: 32 cycles, Fgf4: 28 cycles, Fgf10: 
35 cycles, Igf1: 32 cycles, Igf1r: 30 cycles, Bmp2: 31 cycles, and glyceraldehyde-3-phosphate dehydrogenase (Gapdh): 
30 cycles) of 10 sec at 98 °C for thermal denaturation and 60 sec at 60 °C for annealing and elongation. The cDNA 
obtained by the PCR reaction was separated by electrophoresis using a 2% agarose gel containing ethidium bro-
mide. Real-time PCR was performed by using the Thermal Cycler Dice Real-Time system (Takara Bio). The 
reaction volume was 25 µL, which contained 2 µL of cDNA, 0.4 µM of sense and antisense primer, and 12.5 µL of 
SYBR Premix Ex Taq II (Takara Bio). The reactions consisted of 40 cycles of 5 sec at 95 °C and 30 sec at 60 °C. The 
mRNA expression of each sample was normalized to that of Gapdh and analysed by the ΔΔCT method. Primers 
used for RT-PCR and real-time PCR are listed in Supplementary Table S2.
Statistical analysis. Data were statistically analysed by Student’s t-test to compare differences between two 
groups. For more than two groups, we used an analysis of variance (ANOVA) followed by the Tukey-Kramer test. 
P values < 0.05 was considered statistically significant.
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